Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/2003
12/31/2003CA2499709A1 Method for diagnosis of colorectal tumors
12/31/2003CA2491803A1 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders
12/31/2003CA2490747A1 Method for generating monoclonal antibodies
12/31/2003CA2490725A1 Devices and methodologies useful in body aesthetics
12/31/2003CA2490636A1 Dichloroacetate in combination with cardioprotective or hemodynamic drugs
12/31/2003CA2490399A1 Novel raag10 cell surface target and a family of antibodies recognizing that target
12/31/2003CA2490392A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
12/31/2003CA2490365A1 Quick dissolve compositions and tablets based thereon
12/31/2003CA2490325A1 Transdermal aerosol compositions
12/31/2003CA2490112A1 Diphenyl azetidinones substituted by acidic groups, method for their production, medicaments containing said compounds and use thereof
12/31/2003CA2490109A1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof
12/31/2003CA2490082A1 Quinuclidine derivatives and pharmaceutical compositions containing the same
12/31/2003CA2489947A1 Treatment of human multiple myeloma by curcumin
12/31/2003CA2489905A1 Osteopontin, oligodendrocytes and myelination
12/31/2003CA2489847A1 Use of cyclothiocarbamate derivatives in treatment of hormone-related conditions
12/31/2003CA2489813A1 Use of thio-oxindole derivatives in treatment of hormone-related conditions
12/31/2003CA2489806A1 Liposomes containing biologically active compounds
12/31/2003CA2489702A1 Novel anticholesterol compositions and method for using same
12/31/2003CA2489545A1 Pharmaceutical compositions for the treatment of systemic inflammatory response syndrome
12/31/2003CA2489540A1 Methods of treating and preventing colitis involving il-13 and nk-t cells
12/31/2003CA2489308A1 Use of taurine for the treatment of alopecia
12/31/2003CA2489024A1 Use of pp2a phosphatase modulators in the treatment of mental disorders
12/31/2003CA2488534A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
12/31/2003CA2488311A1 Combination treatment for depression and anxiety by nk1 and nk3 antagonists
12/31/2003CA2487346A1 Cannabinoid receptor agonists
12/31/2003CA2487266A1 Benzimidazole compounds and their use as estrogen agonists/antagonists
12/31/2003CA2485220A1 Methods for identifying glucose uptake modulators
12/31/2003CA2480892A1 Novel promoter
12/31/2003CA2464539A1 Enhancing treatment of mdr cancer with adenosine a3 antagonists
12/31/2003CA2445515A1 Transcription factor modulating compounds and methods of use thereof
12/30/2003US6670493 Methods and compositions for treating diseases due to androgen deficiency with glucocorticoid receptor antagonist compounds and new compounds
12/30/2003US6670397 Needed for regenerating organs or body parts, following cellular degeneration, injury or amputation; also for treating cancer and autoimmune disease; dedifferentiating cells then stabilization
12/30/2003US6670390 Polyphenols and procyanidins; increasing nitric oxide synthesis
12/30/2003US6670380 Pyridone inhibitors of fatty acid binding protein and method
12/30/2003US6670379 Piperidine compounds for use as ccr-3 inhibitors
12/30/2003US6670376 Aryl aniline β2 adrenergic receptor agonists
12/30/2003US6670364 Antagonists of MCP-1 function and methods of use thereof
12/30/2003US6670355 Rapamycin
12/30/2003US6670349 Asthma
12/30/2003US6670346 Treatment and/or inhibition of the development of osteoporosis, breast cancer, hypercholesterolemia, hyperlipidemia or atherosclerosis in susceptible warm-blooded animals including humans, administering selective estrogen
12/30/2003US6670342 Method of treating hepatitis delta virus infection
12/30/2003US6670341 Phosphocholine moiety covalently conjugated with one or more antiviral agents (e.g. nucleoside analogue, protease inhibitor, etc.) to a lipid backbone
12/30/2003US6670340 6-Mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block
12/30/2003US6670334 Antiinflammatory agent
12/30/2003US6670164 Isolated human kinase proteins
12/30/2003US6670140 Determining whether test compound binds to receptor, selecting compound that binds, determining whether compound increases muscle mass or function in skeletal muscle atrophy model system, identifying compound that modulates mass or function
12/30/2003US6670138 Method of diagnosing ischemic stroke via UCP-2 detection
12/30/2003US6670137 Differential diagnosis of neurological diseases
12/30/2003US6670136 Peptide for use in the treatment of inflammation defects
12/30/2003US6669967 Method for the treatment of symptoms related to normal hormonal variations in women
12/30/2003US6669966 Topically applying oxides of bismuth, cobalt, copper, iron, manganese or praseodymium, as ointments or on bandages to improve neovascularization of injuries or skin disorders
12/30/2003US6669958 Gel delivery vehicles for anticellular proliferative agents
12/30/2003US6669955 Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
12/30/2003US6669951 Using conjugate comprising the compound and a delivery-enhancing transporter wherein the compound is attached to the delivery-enhancing transporter through a linker comprising at least 5 guanidino or amidino moieties
12/30/2003US6669948 Cefuroxime, cefpodoxime, amoxicillin and dioxacillin; first, second, and third dosage forms with different release profiles, reaching a Cmax in < twelve hours
12/30/2003US6669943 Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
12/30/2003US6669938 ImmunoConjucates for cancer diagnosis and therapy
12/30/2003US6669903 Celluose acetate coating for sterilization of Trichophyton (fungi), and enteropathogenic Escherichia coli or methicillin tolerant Staphylococcus aureus
12/30/2003US6669623 One-shelled or multi-shelled nanoscalar particles composed of a core containing iron oxide and of an inner shell with groups capable of forming cationic groups which generates heat when alternating electromagnetic field applied
12/30/2003CA2269474C Method of alleviating pain by means of combining tramadol with an nmda antagonist
12/30/2003CA2052884C Angiotensin 11 antagonists in the treatment of hyperuricemia
12/25/2003WO2003105888A1 Acidic insulin preparations with improved stability
12/25/2003WO2003105846A1 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase iv inhibitors for the treatment of bacterial infections
12/25/2003WO2003105809A1 Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
12/25/2003US20030237101 Stem cell factor; modulation of gene expression
12/25/2003US20030236412 Cyclic AMP-specific phosphodiesterase inhibitors
12/25/2003US20030236301 Liposomal delivery of vitamin E based compounds
12/25/2003US20030236298 Antiinflammatory agents; antihistamines; skin disorders
12/25/2003US20030236292 Novel glucagon antagonists
12/25/2003US20030236286 Central nervous system disorders; cardiovascular disorders; antiischemic agents; psychological disorders
12/25/2003US20030236281 Quinoline derivatives(2)
12/25/2003US20030236272 Method and composition for treatment of diabetes, hypertension, chronic heart failure and fluid retentive states
12/25/2003US20030236265 Bactericides; autoimmune disease; antiinflammatory agents; administering a synergistic mixture of rifamycin and another antibiotic
12/25/2003US20030236262 Dietetics; antidiabetic agents; sexual disorders
12/25/2003US20030236260 Antiarthritic agents; autoimmune diseases; anticholesterol agents; cardiovascular disorders; antiinflammatory agents
12/25/2003US20030236252 Brain disorders, cardiovascular disorders, strokes, Parkinson's disease
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236242 Viricides
12/25/2003US20030236237 Method of treating symptoms of hormonal variation, including hot flashes, using tachykinin receptor antagonist
12/25/2003US20030236235 Method and composition for potentiating the antipyretic action of a nonopioid analgesic
12/25/2003US20030236220 Mucin synthesis inhibitors
12/25/2003US20030236216 For the treatment of diseases mediated by the Hepatitis C Virus
12/25/2003US20030236193 Methods of treatment using specific binding agents of human angiopoietin-2
12/25/2003US20030236192 Method of modifying the release profile of sustained release compositions
12/25/2003US20030236183 Comprises 5-HT4 receptor antagonists/agonists; for treatment of gastrointestinal disorders; veterinary medicine
12/25/2003US20030236182 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
12/25/2003US20030235891 Method for generating monoclonal antibodies
12/25/2003US20030235845 Directing splicing of messenger RNA associated with dystrophin protein for diagnosis and treatment of muscular dystrophy
12/25/2003US20030235842 Map
12/25/2003US20030235820 Detecting and identifying tumor related transcripts associated with cancer; screening and monitoring antiproliferative agents
12/25/2003US20030235812 Diagnosing diabetic disorders via impaired insulin secretion, decreased adenine triphosphate biosynthesis and increased levels of reactive oxygen species
12/25/2003US20030235631 Administering mixtures of phosphodiesterase inhibitors, anxiolytic agents and antidepressants for prophylaxis of psycholical disorders; efficiency
12/25/2003US20030235628 Mixtures of proton pump inhibitor such as lansoprazole and water soluble and insoluble bases, used for prophylaxis of gastrointestinal disorders; neutralization gastric juices
12/25/2003US20030235610 Liposomes containing biologically active compounds
12/25/2003US20030235609 Use of cholinesterase antagonists to treat insulin resistance
12/25/2003US20030235589 Comprises chondroprotective agents, an agent which promotes cartilage anabolic activity, and an agent that inhibits cartilage catabolism; for sustained release; for treatment of neurodegenerative disorders
12/25/2003US20030235588 Thioredoxin (TRX); administering histone deacetylase inhibitors such as trichostatin A; for treating inflammation
12/25/2003US20030235571 Systemic treatment of pathological conditions resulting from oxidative stress and/or redox imbalance
12/25/2003US20030235541 Topical administration of basic antifungal compositions to treat fungal infections of the nails
12/25/2003US20030235535 Administering a Prokineticin 2 receptor antagonist or agonist; control internal body clock and functions
1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 1151